Articles liés à Inflammatory Arthritis in Clinical Practice
Synopsis
There has been a revolution in treatments for inflammatory arthritis. Mostly, this is due to the introduction of biologics, particularly TNF inhibitors. These have changed approach to treatment in two ways. First, they appear substantially more effective than conventional drugs. Second, they are far more expensive than traditional treatment approaches. One consequence of this therapeutic revolution is a need to better understand arthritis and to place the new biological treatments into the context of existing management approaches.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Review
From the reviews:
"A concise, up-to-date review of the pathogenesis, clinical features, and treatment of rheumatoid arthritis and spondyloarthropathies. ... it is aimed at family practitioners, rheumatology trainees, and related specialists, as well as allied health professionals in the field of rheumatology. Considering the clear and concise style of writing, the book would also be of benefit to medical students ... . For practicing rheumatologists, it is a good refresher ... . The straightforward, expert coverage makes it a great addition to the medical library ... ." (Vladimir N Despotovic, Doody’s Review Service, July, 2008)
From the Back Cover
Inflammatory Arthritis in Clinical Practice is intended primarily as a concise practical handbook for general practitioners, rheumatology doctors in training and those in related specialties like orthopaedics. It will also be of interest to specialist nurses and allied health professionals working in the field.
It covers all aspects of the diagnosis and management of rheumatoid arthritis and spondyloarthropathies with chapters on
- Rheumatoid arthritis – pathogenesis, clinical features, laboratory investigations, imaging, predicting outcomes and health economics
- Spondyloarthropathies – pathogenesis, clinical features, laboratory investigations and imaging followed by individual sections on each spondyloarthropathy
- Symptomatic Drug Treatment – analgesics and non-steroidal anti-inflammatory drugs including coxibs
- Disease Modifying Antirheumatic Drugs – methotrexate, leflunomide and other conventional DMARDs, combination therapy, current best practice
- Biologics in Rheumatoid Arthritis – tumour necrosis factor inhibitors and other novel biologics, health economics
- Systemic and Local Steroids
- Non-pharmacological therapy – multidisciplinary approach, communication and patient education, physiotherapy, occupational therapy, podiatry, surgery, dietary interventions and complementary therapies
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
